EP1353622A4 - METHOD FOR IMPROVING SYSTEMIC EXPOSURE OF SUBCUTANE-APPLIED THERAPEUTIC PROTEINS - Google Patents

METHOD FOR IMPROVING SYSTEMIC EXPOSURE OF SUBCUTANE-APPLIED THERAPEUTIC PROTEINS

Info

Publication number
EP1353622A4
EP1353622A4 EP01273890A EP01273890A EP1353622A4 EP 1353622 A4 EP1353622 A4 EP 1353622A4 EP 01273890 A EP01273890 A EP 01273890A EP 01273890 A EP01273890 A EP 01273890A EP 1353622 A4 EP1353622 A4 EP 1353622A4
Authority
EP
European Patent Office
Prior art keywords
therapeutic proteins
systemic exposure
subcutaneously administered
administered therapeutic
improving systemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01273890A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1353622A2 (en
Inventor
Charles B Davis
Amarnath Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1353622A2 publication Critical patent/EP1353622A2/en
Publication of EP1353622A4 publication Critical patent/EP1353622A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01273890A 2000-11-03 2001-11-01 METHOD FOR IMPROVING SYSTEMIC EXPOSURE OF SUBCUTANE-APPLIED THERAPEUTIC PROTEINS Withdrawn EP1353622A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24561800P 2000-11-03 2000-11-03
US245618P 2000-11-03
PCT/US2001/051617 WO2002083063A2 (en) 2000-11-03 2001-11-01 Method of improving systemic exposure of subcutaneously administered therapeutic proteins

Publications (2)

Publication Number Publication Date
EP1353622A2 EP1353622A2 (en) 2003-10-22
EP1353622A4 true EP1353622A4 (en) 2005-06-22

Family

ID=22927410

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01273890A Withdrawn EP1353622A4 (en) 2000-11-03 2001-11-01 METHOD FOR IMPROVING SYSTEMIC EXPOSURE OF SUBCUTANE-APPLIED THERAPEUTIC PROTEINS

Country Status (4)

Country Link
EP (1) EP1353622A4 (ja)
JP (1) JP2004532843A (ja)
AU (1) AU2001297793A1 (ja)
WO (1) WO2002083063A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008033499A2 (en) * 2006-09-14 2008-03-20 The Trustees Of The University Of Pennsylvania Modulation of regulatory t cells by human il-18

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1013763A1 (en) * 1997-08-07 2000-06-28 Toray Industries, Inc. CANINE INTERLEUKIN 18, CANINE INTERLEUKIN 1$g(b) CONVERTASE, DNA SEQUENCES ENCODING THE SAME, PROCESS FOR PRODUCING INTERLE UKIN 18, AND REMEDIES FOR CANINE IMMUNOLOGICAL DISEASES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5993527A (en) * 1994-11-17 1999-11-30 Canon Kabushiki Kaisha Ink-jet color recording process and ink set therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1013763A1 (en) * 1997-08-07 2000-06-28 Toray Industries, Inc. CANINE INTERLEUKIN 18, CANINE INTERLEUKIN 1$g(b) CONVERTASE, DNA SEQUENCES ENCODING THE SAME, PROCESS FOR PRODUCING INTERLE UKIN 18, AND REMEDIES FOR CANINE IMMUNOLOGICAL DISEASES

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HERZYK, D. J. [REPRINT AUTHOR] ET AL: "Activity of human interleukin - 18 in cynomolgus monkey.", FASEB JOURNAL, (APRIL 20, 2000) VOL. 14, NO. 6, PP. A1181. PRINT. MEETING INFO.: JOINT ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS AND THE CLINICAL IMMUNOLOGY SOCIETY. SEATTLE, WASHINGTON, USA. MAY 12-16, 2000. CODEN: FAJOEC. ISSN: 08, April 2000 (2000-04-01), XP008046234 *
See also references of WO02083063A3 *

Also Published As

Publication number Publication date
WO2002083063A2 (en) 2002-10-24
JP2004532843A (ja) 2004-10-28
AU2001297793A1 (en) 2002-10-28
EP1353622A2 (en) 2003-10-22
WO2002083063A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
PL335974A1 (en) Method of orally administering proteins
HUP0301164A3 (en) Method of administering bisphosphonates
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
EP1165048A4 (en) COMPOSITIONS AND METHOD FOR IMPROVED ADMINISTRATION OF IONIZABLE HYDROPHOLE THERAPEUTIC SUBSTANCES
PL363322A1 (en) Combination therapy using anti-egfr antibodies and anti-hormonal agents
IL158831A0 (en) METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
EP1404343A4 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES
IL157161A (en) Methods for treating disease states comprising administration of low levels of antibodies
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
IL141553A0 (en) Drug preparations for treating sexual dysfunction
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
NO20026212D0 (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
AU5937901A (en) Combination therapy of respiratory diseases using antibodies
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
EP1353622A4 (en) METHOD FOR IMPROVING SYSTEMIC EXPOSURE OF SUBCUTANE-APPLIED THERAPEUTIC PROTEINS
AU2002222557A1 (en) Interferon therapeutic effect-potentiating agents
IL155819A0 (en) Methods of treatment comprising administration of substance p
IL156655A0 (en) Hormone replacement therapy method and its administration form
AU2002360696A1 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
SI1591122T1 (sl) Postopek za aplikacijo bisfosfonatov
AU2001253336A1 (en) Method 0f administration of paclitaxel-plasma protein formulation
IL144762A0 (en) Liposome composition and method for administration of radiosensitizer
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents
SI1117421T1 (en) Methods for therapeutic vaccination
AU2002328905A1 (en) A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030506

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050511

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 35/00 B

Ipc: 7A 61P 33/00 B

Ipc: 7A 61P 31/00 B

Ipc: 7A 61K 6/00 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080603